Improving treatment for opioid use disorder in community programs
Pilot Implementation of Measurement-Based Care in Community Opioid Treatment Programs
This study is looking to improve how we treat opioid use disorder by using feedback from patients to create better, personalized treatment plans in community programs, making it easier for everyone to get the help they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11045605 on NIH RePORTER |
What this research studies
This research aims to enhance the treatment of opioid use disorder (OUD) by implementing measurement-based care (MBC) in community opioid treatment programs (OTPs). MBC involves using patient self-reported data to tailor and improve treatment plans, addressing the limitations of current pharmacotherapy approaches. The project will engage with multiple OTPs to develop partnerships and gather insights from treatment providers and patients through interviews and surveys. By focusing on flexible psychosocial interventions, the research seeks to overcome barriers that prevent effective treatment in high-volume settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals receiving treatment for opioid use disorder in community opioid treatment programs.
Not a fit: Patients who are not currently engaged in treatment for opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and higher abstinence rates for patients with opioid use disorder.
How similar studies have performed: Previous research has shown that measurement-based care can enhance treatment outcomes in various settings, indicating potential success for this approach in opioid treatment.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Scott, Kelli — Northwestern University at Chicago
- Study coordinator: Scott, Kelli
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.